Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Baihu Tang is a Traditional Chinese Medicine (TCM) formula derived from the classic Baihu Tang (White Tiger Decoction). The base formula consists of Gypsum fibrosum, Rhizoma Anemarrhenae, Radix Glycyrrhizae, and Semen Oryzae Sativae. Modifications typically involve adding herbs like Radix Rehmanniae or Radix Trichosanthis to enhance its heat-clearing and fluid-engendering properties. It is primarily used to treat conditions characterized by "excessive heat," such as Type 2 Diabetes Mellitus (T2DM), acute febrile diseases, and inflammatory conditions. Its mechanism involves regulating glucose metabolism, reducing systemic inflammation, and modulating the gut microbiota. Pharmacological studies suggest it acts by inhibiting pro-inflammatory cytokines and activating metabolic pathways like AMPK.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified baihu tang.